Clinical trial
Thorough QT Study of Nelfinavir
NCT00312182 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00312182 |
|---|---|
| Title | Thorough QT Study of Nelfinavir |
| Official title | Evaluation Of The Effect Of Nelfinavir On QT Intervals At Steady-State After Twice-Daily Administration Of Nelfinavir Tablets To Healthy Volunteers |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy Volunteers |
| Intervention type | Drug |
| Interventions | Nelfinavir |
| Enrollment | 68 |
| Start date | Mar 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Apr 7, 2006 |
| Last update posted | Apr 10, 2009 |
| Countries | Belgium, Singapore, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: